Open AccessCOVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTI-INFLAMMATORY AND ANTICOAGULANT DRUGS USED
Author(s) -
Idrys Henrique Leite Guedes,
Gregório Dantas dos Santos,
Antônio Bonildo Freire Viana,
Geldane da Silva Araújo,
Tálio Câmara Pinto dos Santos,
Cláudia Jassica Gonçalves Moreno,
Silvia Donato
Publication year - 2021
Publication title -
health and society
Language(s) - English
Resource type - Journals
ISSN - 2763-5724
DOI - 10.51249/hes01.04.2021.454
Subject(s) - pandemic , coronaviridae , medicine , covid-19 , outbreak , coronavirus , intensive care medicine , disease , infectious disease (medical specialty) , virology
Since December 2019, an outbreak of viral infection causing respiratory disease with a new virus, the Coronaviridae family, emerged in the city of Wuhan, China to worldwide. With initial symptoms similar to Coronavirus related to Severe Acute Respiratory Syndrome (SARS) and an increase in the speed of spread the World Health Organization (WHO) decrees a pandemic situation on March 11, 2020. Moreover, approximately 3.4 million deaths worldwide and 165 million cases were confirmed. Thus, contributing to an important global health problem responsible for changes in economic and social paradigms. There is no available treatment for COVID-19 until today. Although, several drugs are being used as alternative therapeutics against the diseases, mainly in severe cases. This review aimed to highlight the current anti-inflammatory and anticoagulant alternatives treatment measures for control of COVID 19 infection. Here we discuss the drugs, pharmacological proprieties, and the respective studies COVID-19 related, and also, several research protocols to respond and control the pandemic for the prophylaxis and treatment.